secwatch.observer — SEC 8-K summary
======================================

Issuer:     Guardant Health, Inc. (GH)
CIK:        0001576280
Form:       8-K
Filed at:   2023-12-21T23:59:59+00:00
Accession:  0001193125-23-301187
Event type: other_material
Sentiment:  positive
Materiality: 0.70
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Guardant Health raises $90.7M in registered direct offering with Baillie Gifford
--------------------------------------------------------------------------------

- Raised ~$90.7M gross via 3,387,446 shares sold at $26.77 each to Baillie Gifford-managed accounts.
- Net proceeds ~$90.6M; funds earmarked for general corporate purposes including working capital and capex.
- Offering closed Dec 21, 2023; executed under effective shelf registration statement on Form S-3.
- CEO Helmy Eltoukhy noted strong support from Baillie Gifford as Guardant expands precision oncology portfolio.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1576280/000119312523301187/0001193125-23-301187-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1576280/000119312523301187/d518375d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-301187

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer